ClinicalTrials.gg
Drug

Lenalidomide clinical trials

Also written Revlimid, CC-5013 and CDC 501.

studies test it
751
open now
101
in phase 3
90
first study started
2002

How each study uses Lenalidomide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lenalidomide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Dec 2005 · REVLIMID · NDA 021880 (FDA, Drugs@FDA)
European Union
14 Jun 2007 · Revlimid · EMEA/H/C/000717 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lenalidomide
601
IMiD-1
28
Lenalidomide (Revlimid)
8
Lenalidomide capsule
6
Revlimid (lenalidomide)
6

Brand

Revlimid
378
Revlimid 25mg
1
Revlimid 5 mg
1

Development codes

CC-5013
177
CDC 501
78
SYP-1512
1

In one entry with another drug

Given together, or one or the other

Lenalidomide and dexamethasone
6
Lenalidomide, Bortezomib
3
Lenalidomide, Dexamethasone
3
Lenalidomide and R-CHOP
2
Lenalidomide plus dexamethasone
2

Studies by the year they started

749 studies that test it; most in 2009 (68); 2 more planned to start later

Studies that test Lenalidomide, by start year
YearStudies
20028
20038
200416
200529
200623
200730
200854
200968
201063
201140
201247
201328
201425
201526
201630
201725
201821
201929
202036
202123
202236
202320
202427
202523
202614

Who runs them

Industry 108 · Other 643

M.D. Anderson Cancer Center (46) · Celgene (43) · National Cancer Institute (NCI) (42) · Mayo Clinic (24) · Celgene Corporation (23) · Memorial Sloan Kettering Cancer Center (19) · Dana-Farber Cancer Institute (12) · H. Lee Moffitt Cancer Center and Research Institute (12)

Often tested with

Tested in the same studies.

Dexamethasone (170) · Rituximab (95) · Bortezomib (57) · Daratumumab (36) · Cyclophosphamide (29) · Carfilzomib (25) · Obinutuzumab (21) · Azacitidine (21)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 12 phase 3 studies under way

Lenalidomide is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 43, 5 in phase 3

Studies that test Lenalidomide, phase 3 first.

Studies

Open first, then newest update. How each study uses Lenalidomide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 751

See all 751 studies that test Lenalidomide →

Given beside what is tested · 264 — Lenalidomide is usual care or a partner of the new treatment

Showing 20 of 264.

As the comparator · 22 — what is tested is compared with Lenalidomide

Showing 20 of 22.

Codes

What other systems call Lenalidomide · ClinicalTrials.gg INT006682

  • MeSH (NLM) D000077269LenalidomideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) F0P408N6V4LENALIDOMIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 342369Confirmed FDA, Wikidata
  • Wikidata Q425681(RS)-lenalidomideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2668LenalidomideOne source FDA
  • DrugBank DB00480One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.